Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Sharps Technology Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.",
"NOTICE OF EXERCISE TO: SHARPS TECHNOLOGY, INC. The undersigned hereby elects to purchase Warrant Shares of the Company pursuant to the terms of the attached Warrant , and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any. Payment shall take the form of : [ ] in lawful money of the United States; or [ ] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2, to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2. Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below: ______________________________...",
"NOTICE OF EXERCISE TO: SHARPS TECHNOLOGY, INC. The undersigned hereby elects to purchase ________________ Warrant Shares of the Company pursuant to the terms of the attached Warrant , and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any. Payment shall take the form of : [ ] in lawful money of the United States; or [ ] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2, to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2. Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below: _____________...",
"Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules",
"Sharps Technology Announces Closing of $5.6 Million Registered Direct and Private Placement"
09/29/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
09/28/2023 8-K Quarterly results
08/22/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/04/2023 8-K Other Events  Interactive Data
08/01/2023 8-K Quarterly results
07/14/2023 8-K Quarterly results
05/26/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
04/25/2023 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]:
04/25/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
04/24/2023 EFFECT Form EFFECT - Notice of Effectiveness:
04/14/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
03/31/2023 10-K Annual Report for the period ended December 31, 2022
02/13/2023 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
02/06/2023 8-K Quarterly results
01/27/2023 8-K Appointed a new director
Docs: "2023 Equity Incentive Plan"
01/10/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Sharps Technology Inc. to Introduce New Specialized Prefillable Syringe Systems in 2023"
12/30/2022 8-K/A Quarterly results
12/28/2022 8-K Quarterly results
12/20/2022 8-K Quarterly results
12/13/2022 8-K Quarterly results
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/10/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. Announce Manufacturing and Research Partnership"
10/06/2022 8-K Quarterly results
10/04/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Certain identified information has been excluded from the exhibit because it is both not material and would likely cause competitive harm to the registrant if publicly disclosed."
09/08/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/15/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/14/2022 8-K Quarterly results
06/08/2022 8-K Quarterly results
05/25/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/06/2022 8-K Quarterly results
04/21/2022 SC 13G Loewenstein David A. reports a 9.6% stake in § 240.13d-2. Sharps Technology, Inc.
04/19/2022 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Underwriting Agreement",
"Warrant Agent Agreement between the Company and VStock Transfer, LLC",
"Amendment to Asset/Share Purchase Agreement",
"Press Release",
"Press Release"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy